%PDF-1.4
%
36 0 obj
<>
endobj
33 0 obj
<>
endobj
222 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-09-13T14:12:45Z
2024-03-29T00:00:37-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T00:00:37-07:00
application/pdf
Heather
2004-32.oct
uuid:988ca281-1dd1-11b2-0a00-ec08275dc400
uuid:988ca284-1dd1-11b2-0a00-810000000000
endstream
endobj
22 0 obj
<>
endobj
23 0 obj
<>
endobj
37 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 12 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 14 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 16 0 R/Type/Page>>
endobj
234 0 obj
[239 0 R]
endobj
235 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6234 0.7818 -0.7818 0.6234 10.4844 52.3976 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 587 -785 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.0135 Tw 9.7 0 0 10 40.968 739.1616 Tm
(must further consider that the same clinical phenotype can be)Tj
0.0811 Tw 0 -1.2 TD
(seen in remarkably diverse genetic and environmental back-)Tj
0 Tc 0 Tw T*
(grounds.)Tj
/T1_2 1 Tf
-0.00011 Tc 0 -2.4 TD
(REFERENCES)Tj
/T1_1 1 Tf
0.02499 Tw 7.76 0 0 8 48.18 681.1616 Tm
[(1.)-732 (Laval SH, )18 (T)35 (imms )55 (A, Edwards S, et al. )18 (Whole-genome screening in)]TJ
1.4823 -1.25 Td
(ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility)Tj
0 -1.25 TD
[(loci. )55 (Am J Hum Genet 2001;68:918-26.)]TJ
-1.4823 -1.25 Td
[(2.)-732 (Hugot JP)111 (, Chamaillard M, Zouali H, et al. )55 (Association of NOD2)]TJ
1.4823 -1.25 Td
(leucine rich repeat variants with susceptibility to CD. Nature)Tj
0 Tc 0 Tw T*
[(2001;41)37 (1:599-603.)]TJ
-0.00011 Tc 0.02499 Tw -1.4823 -1.25 Td
[(3.)-732 (Miceli-Richard C, Lesage S, R)40 (ybojad M, et al. CARD15 mutations in)]TJ
1.4823 -1.25 Td
(Blau syndrome. Nat Genet 2001;29:19-20.)Tj
-1.4823 -1.25 Td
[(4.)-732 (Rahman P)111 (, Bartlett S, Siannis F)80 (, et al. )]TJ
/T1_3 1 Tf
16.8784 0 Td
(CARD15 \321 )Tj
/T1_1 1 Tf
[-0.5 (a pleiotropic)]TJ
-15.3961 -1.25 Td
[(autoimmune gene that confers susceptibility to psoriatic arthritis. )55 (Am)]TJ
T*
(J Hum Genet 2003;73:677-81.)Tj
-1.4823 -1.25 Td
[(5.)-732 (Mielants H, )18 (V)111 (eys EM, Goemaere S, Goethals K, Cuvelier C, De )18 (V)129 (os)]TJ
1.4823 -1.25 Td
(M. Gut inflammation in spondyloarthropathies: clinical, radiologic,)Tj
T*
(biologic and generic features in relation to the type of histology: a)Tj
T*
[(prospective study)65 (. J Rheumatol 1991;18:1542-51.)]TJ
-1.4823 -1.25 Td
[(6.)-732 (van der Paardt M, Crusius JB, de Koning MH, et al. CARD15 gene)]TJ
1.4823 -1.25 Td
(mutations are not associated with ankylosing spondylitis. Genes)Tj
T*
(Immunol 2003;4:77-8.)Tj
-1.4823 -1.25 Td
[(7.)-732 (Ferreiros-V)60 (idal I, )55 (Amarelo J, Barros F)80 (, Carracedo )55 (A, Gomez-Reino JJ,)]TJ
1.4823 -1.25 Td
[(Gonzalez )55 (A. Lack of association of ankylosing spondylitis with the)]TJ
T*
[(most common NOD2 susceptibility alleles to Crohn\325)55 (s disease. )]TJ
T*
(J Rheumatol 2003;30:102-4.)Tj
32.4095 33.671 Td
[(8.)-732 (D\325Amato M. )18 (The Crohn\325)55 (s associated NOD2 3020InsC frameshift)]TJ
1.4823 -1.25 Td
(mutation does not confer susceptibility to ankylosing spondylitis. )Tj
T*
(J Rheumatol 2002;29:2470-1.)Tj
-1.4823 -1.25 Td
[(9.)-732 (Crane )55 (AM, Bradbury L, van Heel DA, et al. Role of NOD2 variants)]TJ
1.4823 -1.25 Td
[(in spondylarthritis. )55 (Arthritis Rheum 2002;46:1629-33.)]TJ
-1.9823 -1.25 Td
[(10.)-732 (Brown MA, Brophy S, Bradbury L, et al. Identification of major loci)]TJ
1.9823 -1.25 Td
[(controlling clinical manifestations of ankylosing spondylitis. )55 (Arthritis)]TJ
0 Tc T*
(Rheum 2003;48:2234-9.)Tj
-0.00011 Tc -1.9454 -1.25 Td
[(1)37 (1.)-732 (Moll JM, )18 (W)40 (right )18 (V)129 (. New )37 (Y)100 (ork clinical criteria for ankylosing)]TJ
1.9454 -1.25 Td
[(spondylitis. )55 (A)-220 (statistical evaluation. )55 (Ann Rheum Dis 1973;32:354-63.)]TJ
-1.9823 -1.25 Td
[(12.)-732 (Hugot JP)111 (, Cho JH. Update on genetics of inflammatory bowel disease.)]TJ
1.9823 -1.25 Td
(Curr Opin Gastroenterol 2002;18:410-5.)Tj
-1.9823 -1.25 Td
[(13.)-732 (Inoue N, )18 (T)70 (amura K, Kinouchi )37 (Y)129 (, et al. Lack of common NOD2 )]TJ
1.9823 -1.25 Td
[(variants in Japanese patients with Crohn\325)55 (s disease. Gastroenterology)]TJ
0 Tc 0 Tw T*
(2002;123:86-91.)Tj
-0.00011 Tc 0.00729 Tw -1.9823 -1.25 Td
[(14.)-732 (Y)100 (amazaki )-18 (K, T)70 (akazoe )-18 (M, T)70 (anaka T)74 (, )-18 (Kazumori T)74 (, )-18 (Nakamura )19 (Y)129 (.)]TJ
0.02499 Tw 1.9823 -1.25 Td
(Absence of mutation in the NOD2/CARD15 gene among 483)Tj
T*
[(Japanese patients with Crohn\325)55 (s disease. J Hum Genet 2002;47:469-72.)]TJ
-1.9823 -1.25 Td
[(15.)-732 (Sugimura M, Kinouchi )37 (Y)129 (, )18 (T)70 (akahashi S, et al. CARD15/NOD2 )]TJ
1.9823 -1.25 Td
[(mutational analysis in Japanese patients with Crohn\325)55 (s disease. Clin)]TJ
T*
(Genet 2003;63:160-2.)Tj
-1.9823 -1.25 Td
[(16.)-732 (Lesage S, Zouali H, Cezard JP)111 (, et al. CARD15/NOD2 mutational)]TJ
1.9823 -1.25 Td
(analysis and genotype/phenotype correlation in 612 patients with)Tj
T*
[(inflammatory bowel disease. )55 (Am J Hum Genet 2002;70:845-57.)]TJ
ET
0 0 0 1 K
39.97 81 m
544.97 81 l
S
0 0 0 0 k
480.79 73.86 64.18 -15.66 re
f*
BT
0 0 0 1 k
/T1_3 1 Tf
0 Tc 0 Tw 8 0 0 8 527.968 60.9344 Tm
(1961)Tj
ET
0 0 0 0 k
40.03 75 203 -15.66 re
f*
BT
0 0 0 1 k
/T1_3 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 41.032 62.0695 Tm
[(Kim, et al: CARD15 in Kor)37 (ean )18 (AS)]TJ
ET
0 0 0 0 k
/GS0 gs
94.75 87.08 396.48 -10.83 re
f*
0.5 w
94.75 87.08 396.48 -10.83 re
S
Q
Q
q
1 0 0 1 0 10 cm
0 0 612 792 re
W n
1 0 0 1 0 -10 cm
BT
0 0 0 rg
ET
/GS2 gs
BT
/T1_4 8 Tf
110.368 79 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
16 0 obj
<>stream
8;Z\5d1V$b%.!rn@"1ZWQF%ZDK8H01c)CqSac\8uWeEZmLaYLBm1.t@A*!^"=.OEG
-+0AIScVtf?4_FZ!`d\?/dV%_m)f[[]bSTR5RVV+c=$Y`8sl<*GNWY(+_F:l3?+so
9t,;l?"sq#e1LBJ69/TUEJRDMZEHP;pIAgB@'hBG;o'\#V;'5Vo_%,pl_Mlr_=lY7
'202SgX7G-8e79)<"1ssH)#h0P(%QBKr_V=lS#S(;Y7dl+m]jUJNm(oj&lWTDTffP
H6dsSAM@ehAS1]opVI/TKfPrr()T%4M(hU\2j_*$MA:i?1A.%n2[]S.bYL(gK7Yj0
?a4+ld@LicfhM(UH;(Y,,SHto5MZ/!-csKP+`Lh12ES6o$J/I(n^i?V0cRVRWb]3,
]U=I?Thm-O$ACg?:aeF9q%SldB#6g??/9\3dYgHN/m\V[K]:;.~>
endstream
endobj
20 0 obj
[/Indexed/DeviceRGB 255 19 0 R]
endobj
19 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
85 0 obj
<>
endobj
43 0 obj
<>
endobj
62 0 obj
<>
endobj
41 0 obj
<>
endobj
78 0 obj
<>
endobj
228 0 obj
<>
endobj
44 0 obj
<>
endobj
71 0 obj
<>stream
HU{PSg
"[WقV[EDAZTQ @#!!2 FEPX_[D;EeVg2S?vv??o̙so|Ǭ0ǝÃ.6K⒅7A/`"b ElN/HeI |Y̼NJXe8F H8Ĉ0TD&`odR2'ΌqBj習ᖃQ6
s}d$ [a(,i-e{XLZai5J֎j$3#d&A؆¬Y٩ڭ;1gќ9oQsys[=u|;uR:}M_,s0o<>wstGz_&{sG.^?yv0Q^T+㍲S*qvJ8W4rHkr]81Dv(}+sL4hxCmmFc[[Q$yrMfw.pAG'ǮV+@.hAc{۲7t=uZ.v]~1lS-◈ C{3LEUuڕgMx LQRw "XwrZӈ <:Sex:H[B̌ܙt8'}ű*/n7oq$z7-vk$<~?4W
Xw/"Rv +\]QuoSMزĦLvd@g\ep0b~L76o9[T2Q(Bw%
$se "a贜$H}IR,/vV5V>oyy